A new proposal for benefit-less-risk analysis in clinical trials
- 28 February 1994
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 15 (1) , 30-43
- https://doi.org/10.1016/0197-2456(94)90026-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pitfalls in the Drug Approval Process: Dose-Effect, Experimental Design, and Risk-Benefit IssuesDrug Information Journal, 1992
- Organization and analysis of safety data using a multivariate approachStatistics in Medicine, 1992
- Three measures for simultaneously evaluating benefits and risks using categorical data from clinical trialsStatistics in Medicine, 1991
- Quality adjusted survival analysisStatistics in Medicine, 1990
- Reporting clinical trials from the viewpoint of a patient's choice of treatmentStatistics in Medicine, 1987
- Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are consideredThe American Journal of Medicine, 1986
- Double-blind, placebo-controlled trial of propranolol given once, twice and four times daily in stable angina pectoris: A multicenter study using serial exercise testingThe American Journal of Cardiology, 1984
- Photochemotherapy of psoriasis: Risk : benefit ratiosJournal of the American Academy of Dermatology, 1981
- A scale for assessing the severity of diseases and adverse drug reactions; Application to drug benefit and riskClinical Pharmacology & Therapeutics, 1979
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977